VLST Corp., a Seattle biotech developing therapeutics for the treatment of autoimmune and inflammatory diseases, has raised an additional $5… Read More
Typically, when things are going well in the startup world, venture capitalists optimistically boost valuations of early-stage companies to reflect… Read More
Earlier this week, the Ewing Marion Kauffman Foundation issued a blistering report about the venture capital industry, detailing its own experiences investing… Read More